Company: DARE
Filing Date: 2025-06-25
Form Type: 8-K
Source: 0001641172-25-016374
Chunk: 1

Company: Dare Bioscience, Inc.
Filing Date: 2025-06-25
Form: 8-K
Item: Item 8.01
Chunk 1
---
 our common stock on Nasdaq before August 12, 2025, even though the Panel granted us conditional continued listing until August 12,
2025. As is customary, the Panel also reserved the right to reconsider the terms of the extension it granted based on any event, condition
or circumstance that exists or develops that would, in the opinion of the Panel, make continued listing of our common stock inadvisable
or unwarranted. See the risk factor titled, “ If we fail to regain and maintain compliance with the continued listing requirements
of The Nasdaq Capital Market, our common stock could be suspended and delisted, which could, among other things, limit demand for our
common stock, substantially impair our ability to raise additional capital and have an adverse effect on the market price of, and the
efficiency of the trading market for, our common stock,” in Item 1A of Part II our quarterly report on Form 10-Q filed with the
Securities and Exchange Commission (the “ SEC”) on May 13, 2025, and our risk factors in Item 1A of Part I of our annual report
on Form 10-K filed with the SEC on March 31, 2025.

Forward-Looking
Statements

Daré
cautions you that all statements, other than statements of historical facts, contained in this report, are forward-looking statements.
Forward-looking statements, in some cases, can be identified by terms such as “believe,” “may,” “will,”
“estimate,” “continue,” “anticipate,” “design,” “intend,” “expect,”
“could,” “plan,” “potential,” “predict,” “seek,” “should,” “would,”
“contemplate,” “project,” “target,” “objective,” “on track,” or the negative
version of these words and similar expressions. In this report, forward-looking statements include, but are not limited to, statements
relating to plans and expectations with respect to Daré’s ability to successfully execute against its Plan and to regain compliance
with Nasdaq Listing Rule 5550(b). Forward-looking statements involve known and unknown risks, uncertainties and other factors that may
cause Daré’s actual results, performance or achievements to be materially different from future results, performance or achievements
expressed or implied by the forward-looking statements, including, without limitation, risks and uncertainties related to: Daré’s
ability to raise additional capital to increase its stockholders’ equity and